4Filing Date: Feb 26, 2026

Metlife 4: Glaser Daniel S bought 273 shares of Common Stock at $75.34… (Feb 26, 2026)

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0001420864-26-000008
Total Value$20.6K
Trades1
Insiders1

Transaction Details

Glaser Daniel S
Director·Direct
Grant · Acquire
Common Stock
Shares+273
Price$75.34
Total Value$20.6K
Shares Owned After1.58K
Transaction DateFeb 24, 2026
Footnotes ▸

MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Post-Transaction Holdings

Glaser Daniel S · Director
SecuritySharesChange
Common Stock1.58K+273 (20.92%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-02-24 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: METLIFE INC (MET) CIK: 0001099219 --- Reporting Owner --- Name: Glaser Daniel S CIK: 0001420864 Role: Director --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-02-24 | Code: A (Grant or award) Shares: +273 | Price: $75.34 Total Value: $20,567.82 Shares Owned After: 1,578 | Ownership: D (Direct) Footnotes: [F1] MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. --- Footnotes (Complete Index) --- F1: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. --- Signature --- /s/ /s/ Taylor McInerney Jansen, Attorney-in-fact (2026-02-26)

keid analysis is for reference only and does not constitute investment advice.